Last updated: May 8, 2023
Sponsor: Catholic University of the Sacred Heart
Overall Status: Active - Recruiting
Phase
N/A
Condition
Canker Sores
Mucositis
Treatment
Zinc Gluconate
Sodium Bicarbonate
Clinical Study ID
NCT05853692
ID 4576
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with diagnosis of the following HNC: oral cavity, pharynx, unknown primary,salivary glands, undergoing local radiotherapy for curative purpose
- Patients with diagnosis of HNC: oral cavity, pharynx, unknown primary, salivaryglands, undergoing local radiotherapy as an adjuvant to surgical resection
- Patients able self-apply the product.
Exclusion
Exclusion Criteria:
- Patients with documented contraindication to any of the components of "Gel X" (thereincluded eccipients): water, saccharin sodium, PVP, Taurine, Zinc Gluconate, PEG-40,Hydrogenated castor oil, Pullulan, Flavors
- Patients with any neurological and psychiatric condition having an influence on theability to self-apply the treatment
- Patients participating to other clinical studies
Study Design
Total Participants: 130
Treatment Group(s): 2
Primary Treatment: Zinc Gluconate
Phase:
Study Start date:
October 10, 2022
Estimated Completion Date:
June 10, 2026
Connect with a study center
Catholic University of the Sacred Hearth
Roma, 00168
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.